Chronic Traumatic Encephalopathy Within an Amyotrophic Lateral Sclerosis Brain Bank Cohort
Open accessAbstract
Chronic traumatic encephalopathy (CTE) is a progressive neurodegenerative disorder linked to repetitive head impacts and has been associated with amyotrophic lateral sclerosis (ALS), a fatal, degenerative neuromuscular disorder. The Department of Veterans Affairs Biorepository Brain Bank (VABBB) is a tissue repository that collects antemortem disease progression data and postmortem central nervous system tissue from veterans with ALS. We set out to determine the frequency of co-morbid ALS and CTE in the VABBB cohort and to characterize the clinical, genetic, and pathological distinctions between participants with ALS only and those with both ALS and CTE (ALS+CTE). Of 155 participants, 9 (5.8%) had neuropathologically confirmed ALS+CTE. Participants with ALS+CTE were more likely to have a history of traumatic brain injury (p < 0.001), served during the first Persian Gulf War (p < 0.05), and to have more severe tau pathology within the frontal cortex and spinal cord (p < 0.05). The most common exposures to head impacts included contact sports (n = 5) and military service (n = 2). Clinically, participants with ALS+CTE were more likely to have bulbar onset ALS (p = 0.006), behavioral changes (p = 0.002), and/or mood changes (p < 0.001). Overall, compared with ALS in isolation, comorbid ALS+CTE is associated with a history of TBI and has a distinct clinical and pathological presentation.
AI snapshot
Written from the paper’s full text.
TL;DR
In a VA brain bank cohort of 155 deceased veterans with neuropathologically confirmed ALS or related motor neuron disease, 9 (5.8%) had comorbid CTE. ALS+CTE was associated with TBI history, bulbar onset, mood/behavioral changes, and greater tau pathology in frontal cortex and spinal cord.
Key findings
- 9/155 participants (5.8%) had neuropathologically confirmed ALS+CTE; all 9 were male and all had some head-impact history (8 with TBI, 6 with RHI). Of 16 participants with a TBI history, 8 (50%) received a comorbid CTE diagnosis at autopsy.
- Compared with ALS alone, ALS+CTE had significantly more TBI history (8/9 [89%] vs 8/146 [5%], p < 0.001), bulbar onset (56% vs 14%, p = 0.006), mood disorders (78% vs 23%, p = 0.001), and behavioral disorders (44% vs 5%, p = 0.002).
- Tau pathology was increased in ALS+CTE: middle frontal cortex frequency (p = 0.002) and severity (p < 0.001), and spinal cord severity in cervical (p = 0.024), thoracic (p = 0.014), and lumbar (p = 0.007) regions. ALSFRS-R at death (12.9 vs 12.8, p = 0.989) and DFS progression rate (−0.5 vs −0.6, p = 0.689) did not differ significantly.
- Service era differed: ALS+CTE participants were less likely to have served in Vietnam (p < 0.05) and more likely to have served in the first Persian Gulf War (p < 0.05). No known ALS mutations were found in the 5 tested ALS+CTE participants; 9 ALS-only participants had known mutations, including 3 with C9orf72, but differences were not significant.
Methods
- Design: analysis of the Department of Veterans Affairs Biorepository Brain Bank (VABBB), a longitudinal ALS tissue repository. Since 2006, 287 veterans with ALS enrolled; 156 were deceased with complete neuropathological evaluation and cortical/spinal cord tau immunostaining; 1 was excluded for not meeting ALS neuropathological criteria, leaving 155.
- Data: antemortem clinical/functional data collected by telephone interview, mail questionnaires, and medical record review; TBI and RHI defined from history; ALSFRS-R used for motor function. Postmortem neuropathological examination was blinded to clinical features; CTE diagnosed by consensus criteria; tau pathology in dorsolateral frontal cortex and spinal cord scored semiquantitatively 0–3; genetic testing used NeuroChip and OmniExpress.
- Analysis: IBM SPSS Statistics v20; Mann-Whitney U tests, Fisher exact tests, and Pearson chi-squared tests with Bonferroni corrections; alpha = 0.05.
Limitations
- Stated: enrollment via the Durham VA ALS Registry and passive methods may introduce bias; TBI/RHI exposure was determined by retrospective review, which may bias results; the veteran population limits generalizability; and the small number of ALS+CTE participants limits power for many analyses.
- Evident from the text: the cohort was 99% male and 89% White and veteran-only, so findings may not generalize to women, non-veterans, or more diverse populations.
- Evident from the text: missing data affect some comparisons (e.g., RHI data were not available for the majority of ALS-only cases; ALSFRS-R was unavailable for postmortem enrollees; genetic testing was performed in 98 participants), and tau pathology was assessed semiquantitatively at death, when advanced disease may preclude detection of earlier changes.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
29 of 40 cited sources checked · 15 supported · 0 flagged · accuracy not yet measured
- Premisecitation
In a veteran cohort, those with head injury, especially head injuries within 15 years prior to diagnosis, were significantly more likely to have developed ALS.
“Moreover, in a veteran cohort, those with head injury, especially head injuries within 15 years prior to diagnosis, were found to be significantly more likely to have developed ALS (16).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [16] Schmidt, 2010, Association of ALS with head injury, cigarette smoking and APOE genotypes, J Neurol Sci source
The Results (Association of ALS with Head Injury; page not supplied) report significantly higher ALS odds for veterans whose last head injury occurred within 15 years before the reference date (OR 2.33, 95% CI 1.18–4.61). They also state that the absolute number of head injuries was not associated with ALS, so the claim is too broad if it says head injury generally was significantly associated. The paper uses the reference date, rather than diagnosis, for the 15-year interval. (LLM, conf=0.84)
Experimental — accuracy not yet measured
- Premisecitation
TBI may be an environmental risk factor for ALS.
“One such environmental risk factor may be traumatic brain injury (TBI).Chen et al found that individuals were 11 times more likely to develop ALS if they reported multiple head injuries within the last 10 years prior to diagnosis (14)”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [14] Chen, 2007, Head injury and amyotrophic lateral sclerosis, Am J Epidemiol source
- Findingcitation
There was a significantly increased TDP-43 stage using the criteria of Brettschneider et al in participants with ALS+CTE.
“However, there was a significantly increased TDP-43 stage using the criteria of Brettschneider et al in participants with ALSþCTE (27).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [27] Brettschneider, 2013, Stages of pTDP‐43 pathology in amyotrophic lateral sclerosis, Ann Neurol source
- Premisecitation
A recent study demonstrated phosphorylation of tau at Thr 175 and Thr 231 in individuals with CTE and ALS+CTE, but not in participants with sporadic ALS without CTE.
“A recent study demonstrated phosphorylation of tau at Thr 175 and Thr 231 in individuals with CTE and ALSþCTE, but not in participants with sporadic ALS without CTE (45).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [45] Moszczynski, 2018, Pathologic Thr(175) tau phosphorylation in CTE and CTE with ALS, Neurology source
The Abstract Results and Discussion report phosphorylation of tau at Thr175 and Thr231 in CTE and CTE-ALS. The Methods list CTE, CTE-ALS, and neurologically healthy control cases—not participants with sporadic ALS. Although the Discussion mentions an absence of spinal-cord tau deposition in sporadic ALS, this study did not demonstrate the claimed absence of phosphorylation at both sites in such participants. (LLM, conf=0.88)
Experimental — accuracy not yet measured
- Premisecitation
Individuals with ALS are at higher risks for falls compared to the general population.
“In addition, individuals with ALS are at higher risks for falls compared to the general population and therefore may have an increased risk for developing CTE (42).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [42] Kehyayan, 2014, Profile of patients with amyotrophic lateral sclerosis across continuum of care, Can J Neurol Sci source
The Health and Social-Economic Profile reports higher fall rates for people with ALS than for the comparison group in home care. But the Case Ascertainment and Sample Size sections define that group as patients in care settings without specified neurological conditions, not the general population. The cited paper therefore supports a narrower comparison than the claim makes. (LLM, conf=0.88)
Experimental — accuracy not yet measured
- Interpretationcitation
Individuals with ALS may have an increased risk for developing CTE.
“In addition, individuals with ALS are at higher risks for falls compared to the general population and therefore may have an increased risk for developing CTE (42).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [42] Kehyayan, 2014, Profile of patients with amyotrophic lateral sclerosis across continuum of care, Can J Neurol Sci source
The Health and Social-Economic Profile reports higher rates of falls among people with ALS in home care than among the study’s comparison group, not the general population. The paper does not link those falls to chronic traumatic encephalopathy (CTE) or assess CTE risk, so the proposed consequence is unsupported. (LLM, conf=0.86)
Experimental — accuracy not yet measured
- Premisecitation
This finding is similar to a previous report of increased frequency of bulbar onset ALS and a younger age of onset in a group of soccer players.
“This is similar to a previous report of increased frequency of bulbar onset ALS and a younger age of onset in a group of soccer players (43).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [43] Chio, 2005, Severely increased risk of amyotrophic lateral sclerosis among Italian professional football players, Brain source
- Interpretationcitation
The prevalence of CTE found in an MSA cohort is similar to the prevalence found in this study (5.8%).
“The prevalence of CTE found in an MSA cohort is similar to the prevalence found in this study (5.8%), and both populations are at a high risk of falls after the onset of neurological disease.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [46] Koga, 2016, Chronic traumatic encephalopathy pathology in multiple system atrophy, J Neuropathol Exp Neurol source
- Premisecitation
Veterans are at increased risk for ALS development.
“Veterans are at increased risk for ALS development (51) and their exposure to combat, combat training, and contact sports may predispose them to head injuries to a greater degree than the general population, limiting the generalizability of the study.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [51] Saberi, 2015, Neuropathology of amyotrophic lateral sclerosis and its variants, Neurol Clin source
The Introduction and Familial ALS section discuss ALS history and genetic causes, but neither addresses risk among veterans. Searches for military service, veterans, combat, and head injury found no passage in our copy comparing veterans’ ALS risk with that of the general population. (LLM, conf=0.70)
Experimental — accuracy not yet measured
- Findingown data
Participants with ALS+CTE were more likely to have a history of TBI (p<0.001).
“Participants with ALSþCTE were more likely to have a history of traumatic brain injury (p < 0.001)”
- Also stated in: § Demographic, Clinical, and Genetic Characteristics · plain
“As expected, a history of TBI was significantly more prevalent among participants with ALSþCTE than among those with ALS alone (8/9 ALSþCTE [89%] vs 8/146 ALS [5%], p < 0.001).”
Quote in the paperSubstantial claim- Rests on an assumption: Clinical history data (TBI, RHI, mood, behavioral, cognitive) obtained from participant/proxy questionnaires and medical records accurately reflect participants' actual exposures and symptoms.
- Also stated in: § Demographic, Clinical, and Genetic Characteristics · plain
- Findingown data
Participants with ALS+CTE had more severe tau pathology within the frontal cortex and spinal cord (p<0.05).
“and to have more severe tau pathology within the frontal cortex and spinal cord (p < 0.05).”
Quote in the paperSubstantial claim- Rests on an assumption: Semiquantitative tau pathology scores (0-3) reliably reflect severity of tau pathology.
- Findingown data
Participants with ALS+CTE were significantly more likely to have bulbar onset ALS than participants with ALS alone.
“Participants with co-morbid ALSþCTE were significantly more likely to have bulbar onset ALS.”
- Also stated in: § CONCLUSIONS · plain
“Veterans with ALSþCTE had significantly higher frequencies of TBI exposure, bulbar onset ALS, mood and behavioral disorders, and increased ptau pathology in the frontal cortex and spinal cord.”
Quote in the paperSubstantial claim - Also stated in: § CONCLUSIONS · plain
- Findingown data
There were no significant differences between groups in presence of family history of ALS.
“There were no significant differences between groups in the presence of a family history of ALS.”
Quote in the paperNot a substantial claim - Findingown data
Participants with ALS+CTE had significantly more ptau pathology in the frontal cortex and at all levels of the spinal cord compared to participants with ALS alone.
“Participants with ALSþCTE also had significantly more ptau pathology in the frontal cortex and at all levels of the spinal cord.”
- Also stated in: § DISCUSSION · plain
“Pathologically, there was significantly increased ptau pathology in the frontal cortex and all levels of the spinal cord in participants within ALSþCTE compared to ALS alone.”
- Also stated in: § CONCLUSIONS · plain
“Veterans with ALSþCTE had significantly higher frequencies of TBI exposure, bulbar onset ALS, mood and behavioral disorders, and increased ptau pathology in the frontal cortex and spinal cord.”
Quote in the paperSubstantial claim - Also stated in: § DISCUSSION · plain
- Findingown data
Most common exposures to head impacts among ALS+CTE included contact sports (n=5) and military service (n=2).
“The most common exposures to head impacts included contact sports (n ¼ 5) and military service (n ¼ 2).”
Quote in the paperNot a substantial claim- Rests on an assumption: Clinical history data (TBI, RHI, mood, behavioral, cognitive) obtained from participant/proxy questionnaires and medical records accurately reflect participants' actual exposures and symptoms.
- Findingown data
Of 287 total participants, 156 were deceased with complete neuropathological evaluation with cortical and spinal cord tau immunostaining for current analyses.
“Of the 287 total participants enrolled, 156 were deceased with a complete neuropathological evaluation with cortical and spinal cord tau immunostaining for the current analyses.”
Quote in the paperSubstantial claim - Findingown data
Of 155 participants, 9 (5.8%) had neuropathologically confirmed ALS+CTE.
“Of 155 participants, 9 (5.8%) had neuropathologically confirmed ALSþCTE.”
- Also stated in: § Neuropathological Assessment of CTE · plain
“Of the 155 participants with pathologically confirmed ALS or related MND, 9 participants (5.8%) were neuropathologically diagnosed with CTE.”
Quote in the paperSubstantial claim - Also stated in: § Neuropathological Assessment of CTE · plain
- Findingown data
Participants with ALS+CTE were more likely to have served during the first Persian Gulf War (p<0.05).
“served during the first Persian Gulf War (p < 0.05)”
- Also stated in: § Demographic, Clinical, and Genetic Characteristics · plain
“participants with ALSþCTE were less likely to serve in Vietnam (p < 0.05) and more likely to have served in the first Persian Gulf War (p < 0.05, Table 3).”
Quote in the paperNot a substantial claim- Rests on an assumption: Clinical history data (TBI, RHI, mood, behavioral, cognitive) obtained from participant/proxy questionnaires and medical records accurately reflect participants' actual exposures and symptoms.
- Also stated in: § Demographic, Clinical, and Genetic Characteristics · plain
- Findingown data
Participants with ALS+CTE were more likely to have behavioral changes (p=0.002).
“behavioral changes (p ¼ 0.002)”
- Also stated in: § Demographic, Clinical, and Genetic Characteristics · plain
“as well as behavioral disorders (44% vs 5%, p ¼ 0.002).”
Quote in the paperSubstantial claim- Rests on an assumption: Clinical history data (TBI, RHI, mood, behavioral, cognitive) obtained from participant/proxy questionnaires and medical records accurately reflect participants' actual exposures and symptoms.
- Also stated in: § Demographic, Clinical, and Genetic Characteristics · plain
- Findingown data
There was no significant difference between frequencies of cognitive impairment.
“There was no significant difference between the frequencies of cognitive impairment.”
Quote in the paperNot a substantial claim- Rests on an assumption: Clinical history data (TBI, RHI, mood, behavioral, cognitive) obtained from participant/proxy questionnaires and medical records accurately reflect participants' actual exposures and symptoms.
- Findingown data
Participants with ALS+CTE were more likely to have bulbar onset ALS (p=0.006).
“Clinically, participants with ALSþCTE were more likely to have bulbar onset ALS (p ¼ 0.006)”
- Also stated in: § Demographic, Clinical, and Genetic Characteristics · plain
“Clinically, participants with ALSþCTE were more likely to present with bulbar-onset ALS symptoms compared to ALS alone (56% vs 14% p ¼ 0.006).”
Quote in the paperSubstantial claim- Rests on an assumption: Clinical history data (TBI, RHI, mood, behavioral, cognitive) obtained from participant/proxy questionnaires and medical records accurately reflect participants' actual exposures and symptoms.
- Also stated in: § Demographic, Clinical, and Genetic Characteristics · plain
- Findingown data
No mutations were found in any of 5 tested participants with ALS+CTE.
“No mutations were found in any of the 5 tested participants with ALSþCTE.”
Quote in the paperNot a substantial claim - Findingown data
Participants with ALS+CTE had a significantly higher frequency of TBI history than participants with ALS alone.
“The frequency of TBI was significantly higher among participants with ALSþCTE than among participants with ALS only.”
- Also stated in: § CONCLUSIONS · plain
“Veterans with ALSþCTE had significantly higher frequencies of TBI exposure, bulbar onset ALS, mood and behavioral disorders, and increased ptau pathology in the frontal cortex and spinal cord.”
Quote in the paperSubstantial claim - Also stated in: § CONCLUSIONS · plain
- Findingown data
Participants with ALS+CTE had significantly more reported behavioral changes and mood disorders compared to participants with ALS alone.
“In this study, participants with ALSþCTE had significantly more reported behavioral changes and mood disorders compared to participants with ALS alone.”
- Also stated in: § CONCLUSIONS · plain
“Veterans with ALSþCTE had significantly higher frequencies of TBI exposure, bulbar onset ALS, mood and behavioral disorders, and increased ptau pathology in the frontal cortex and spinal cord.”
Quote in the paperSubstantial claim - Also stated in: § CONCLUSIONS · plain
- Findingown data
In the cohort of 155 veterans with pathologically confirmed ALS or related MND, 9 participants (5.8%) had a comorbid diagnosis of CTE.
“In this cohort of 155 veterans with pathologically confirmed ALS or related MND, 9 participants (5.8%) had a comorbid diagnosis of CTE.”
- Also stated in: § CONCLUSIONS · plain
“We examined a cohort of 155 veteran ALS brain donors for co-morbid CTE and found it in 5.8% of participants.”
Quote in the paperSubstantial claim - Also stated in: § CONCLUSIONS · plain
- Findingown data
Participants with ALS+CTE had slightly younger, but non-significant, age at death (63.3 years) than ALS alone (70.7 years; p=0.128).
“Participants with ALSþCTE had a slightly younger, but non-significant, age at death (63.3 years) than ALS alone (70.7 years; p ¼ 0.128).”
Quote in the paperNot a substantial claim - Findingown data
Mean disease duration was not significantly different between groups.
“Mean disease duration was not significantly different between groups.”
Quote in the paperNot a substantial claim - Findingown data
Participants with ALS+CTE were more likely to have mood changes (p<0.001).
“and/ or mood changes (p < 0.001).”
- Also stated in: § Demographic, Clinical, and Genetic Characteristics · plain
“significantly more likely to have mood disorders (78% vs 23%, p ¼ 0.001)”
Quote in the paperSubstantial claim- Rests on an assumption: Clinical history data (TBI, RHI, mood, behavioral, cognitive) obtained from participant/proxy questionnaires and medical records accurately reflect participants' actual exposures and symptoms.
- Also stated in: § Demographic, Clinical, and Genetic Characteristics · plain
- Findingown data
Of 16 participants with history of TBI, 8 (50%) received co-morbid CTE diagnosis at autopsy.
“Of the 16 participants with a history of TBI, 8 (50%) received a co-morbid CTE diagnosis at autopsy.”
Quote in the paperNot a substantial claim- Rests on an assumption: Clinical history data (TBI, RHI, mood, behavioral, cognitive) obtained from participant/proxy questionnaires and medical records accurately reflect participants' actual exposures and symptoms.
- Findingown data
Regions most frequently involved by CTE ptau pathology were middle frontal gyrus (8/9), superior temporal gyrus (9/9), inferior parietal lobule (7/9), and hippocampus (7/9).
“The regions most frequently involved by CTE ptau pathology were the middle frontal gyrus (8/9), superior temporal gyrus (9/9), inferior parietal lobule (7/9), and hippocampus (7/ 9).”
Quote in the paperNot a substantial claim- Rests on an assumption: Semiquantitative tau pathology scores (0-3) reliably reflect severity of tau pathology.
- Findingown data
Beta-amyloid plaques were present in 5 participants (CTE-4,5,6,7,8).
“Beta-amyloid plaques were present in 5 participants (CTE-4, CTE-5, CTE-6, CTE-7, and CTE-8).”
Quote in the paperNot a substantial claim- Rests on an assumption: Semiquantitative tau pathology scores (0-3) reliably reflect severity of tau pathology.
- Findingown data
There were no significant differences between ALS+CTE and ALS alone in median CERAD score.
“There were no significant differences between groups in the frequency of comorbid Lewy body disease, median Braak NFT stage, median CERAD score, or median Thal phase.”
Quote in the paperNot a substantial claim - Findingown data
There were no significant differences between ALS+CTE and ALS alone in brain weight.
“There were no significant differences in brain weight or severity of upper motor neuron or lower motor neuron degeneration.”
Quote in the paperNot a substantial claim - Findingown data
The frequency of tau pathology was increased within the middle frontal cortex in participants with ALS+CTE compared to participants with ALS alone (p=0.002).
“Both the frequency of tau pathology and its severity were increased within the middle frontal cortex (p ¼ 0.002 and p < 0.001 respectively) in participants with ALSþCTE compared to participants with ALS alone.”
Quote in the paperSubstantial claim - Findingown data
The severity of tau pathology was increased within the middle frontal cortex in participants with ALS+CTE compared to participants with ALS alone (p<0.001).
“Both the frequency of tau pathology and its severity were increased within the middle frontal cortex (p ¼ 0.002 and p < 0.001 respectively) in participants with ALSþCTE compared to participants with ALS alone.”
Quote in the paperSubstantial claim - Findingown data
There were no significant differences between ALS+CTE and ALS alone in median Thal phase.
“There were no significant differences between groups in the frequency of comorbid Lewy body disease, median Braak NFT stage, median CERAD score, or median Thal phase.”
Quote in the paperNot a substantial claim - Findingown data
There was a nonsignificant increased frequency of co-morbid frontotemporal lobar degeneration in participants with ALS+CTE vs participants with only ALS (11% vs 3%, p=0.306).
“There was a nonsignificant increased frequency of co-morbid frontotemporal lobar degeneration in participants with ALSþCTE vs participants with only ALS (11% vs 3%, p ¼ 0.306).”
Quote in the paperNot a substantial claim - Findingown data
There were no significant differences in the frequency of cognitive impairment between ALS+CTE and ALS alone.
“There were no significant differences in the frequency of cognitive impairment between groups.”
Quote in the paperSubstantial claim - Findingown data
There was no significant difference in the frequency of TDP-43 inclusions between ALS+CTE and ALS alone (78% vs 71%, p=1.000).
“There was no significant difference in the frequency of TDP-43 inclusions between groups (78% vs 71%, p ¼ 1.000).”
Quote in the paperNot a substantial claim - Findingown data
Of participants with a positive history of TBI, 50% were found to have co-morbid CTE.
“Of participants with a positive history of TBI, 50% were found to have co-morbid CTE.”
Quote in the paperSubstantial claim - Findingown data
There were no significant differences between ALS+CTE and ALS alone in median Braak NFT stage.
“There were no significant differences between groups in the frequency of comorbid Lewy body disease, median Braak NFT stage, median CERAD score, or median Thal phase.”
Quote in the paperNot a substantial claim - Findingown data
There were no significant differences between ALS+CTE and ALS alone in the frequency of comorbid Lewy body disease.
“There were no significant differences between groups in the frequency of comorbid Lewy body disease, median Braak NFT stage, median CERAD score, or median Thal phase.”
Quote in the paperNot a substantial claim - Findingown data
In participants with ALS+CTE, the frequency of mood disorders was 78%.
“In contrast, in participants with ALSþCTE, the frequency of mood disorders was much higher (78%).”
Quote in the paperSubstantial claim - Findingown data
Within ALS+CTE participants, the severity of tau pathology was significantly increased with higher median semiquantitative tau pathology scores in cervical, thoracic, and lumbar spinal cord regions (p=0.024, 0.014, 0.007 respectively).
“Furthermore, within ALSþCTE participants there was a trend toward increased frequency of tau pathology at all levels of the spinal cord, and the severity of tau pathology was significantly increased with higher median semiquantitative tau pathology scores within cervical (p ¼ 0.024), thoracic (p ¼ 0.014), and lumbar (p ¼ 0.007) regions.”
Quote in the paperSubstantial claim - Findingown data
DFS rates were not significantly different between participants with ALS+CTE and ALS only.
“Although bulbar onset ALS has been associated with faster disease progression (44), DFS rates were not significantly different between participants with ALSþCTE and ALS only although this analysis is likely underpowered due to the small number of participants with CTE.”
Quote in the paperNot a substantial claim - Findingown data
There were no significant differences between ALS+CTE and ALS alone in severity of upper motor neuron or lower motor neuron degeneration.
“There were no significant differences in brain weight or severity of upper motor neuron or lower motor neuron degeneration.”
Quote in the paperNot a substantial claim - Findingown data
Within ALS+CTE participants, there was a trend toward increased frequency of tau pathology at all levels of the spinal cord.
“Furthermore, within ALSþCTE participants there was a trend toward increased frequency of tau pathology at all levels of the spinal cord, and the severity of tau pathology was significantly increased with higher median semiquantitative tau pathology scores within cervical (p ¼ 0.024), thoracic (p ¼ 0.014), and lumbar (p ¼ 0.007) regions.”
Quote in the paperNot a substantial claim - Findingown data
A history of head impact was present in all participants with ALS+CTE.
“A history of head impact was present in all participants with ALSþCTE and consisted of a single or multiple mild to severe TBI, RHI, or both.”
Quote in the paperSubstantial claim - Interpretationnone given
Assessment at death when the disease is advanced may preclude detection of changes earlier in the disease course.
“Although there were no significant differences between the degree of degeneration in the upper or lower motor neuron pathways in ALSþCTE compared to ALS alone, assessment at death when the disease is advanced may preclude detection of changes earlier in the disease course.”
Quote in the paperSubstantial claim - Interpretationown data
There were distinct clinical and pathological differences between participants with ALS+CTE and ALS alone.
“There were also distinct clinical and pathological differences between participants with ALSþCTE and ALS alone.”
Quote in the paperSubstantial claim - Interpretationown data
The lack of known ALS-associated genetic variation in ALS+CTE supports the idea that RHI may be an environmental cause of ALS as well as CTE.
“Although the sample size is limited, the lack of known ALS-associated genetic variation in ALSþCTE supports the idea that RHI may be an environmental cause of ALS as well as CTE.”
Quote in the paperSubstantial claim - Study design and conductreasoning
Methods for determination of TBI and RHI exposure were based on retrospective review, which may introduce bias.
“Methods for determination of TBI and RHI exposure were based on retrospective review, which may also introduce bias.”
Quote in the paperNot a substantial claim - Interpretationreasoning
The frontal cortex ptau pathology of CTE may underlie the increased frequency of behavioral and mood disorders in participants with ALS+CTE.
“The frontal cortex ptau pathology of CTE may underlie the increased frequency of behavioral and mood disorders in participants with ALSþCTE.”
Quote in the paperSubstantial claim - Interpretationnone given
This is the largest screen of participants with ALS for CTE to date.
“Although this is the largest screen of participants with ALS for CTE to date, the relatively small number of participants with ALSþCTE limits the power of many of the analyses.”
Quote in the paperNot a substantial claim - Interpretationreasoning
The prevalence of cognitive impairment, as well as mood and behavioral dysfunction, may be underreported because detection of these changes can be masked by communication difficulties caused by progressive ALS symptomology.
“However, the prevalence of cognitive impairment, as well as mood and behavioral dysfunction, may be underreported as detection of these changes can be masked by communication difficulties caused by progressive ALS symptomology.”
Quote in the paperNot a substantial claim - Study design and conductown data
The analysis of DFS rates is likely underpowered due to the small number of participants with CTE.
“Although bulbar onset ALS has been associated with faster disease progression (44), DFS rates were not significantly different between participants with ALSþCTE and ALS only although this analysis is likely underpowered due to the small number of participants with CTE.”
Quote in the paperSubstantial claim - Interpretationown data
TBI from a variety of sources were associated with the development of CTE in this cohort.
“TBI from a variety of sources were associated with the development of CTE in this cohort.”
Quote in the paperSubstantial claim - Study design and conductown data
The relatively small number of participants with ALS+CTE limits the power of many of the analyses.
“Although this is the largest screen of participants with ALS for CTE to date, the relatively small number of participants with ALSþCTE limits the power of many of the analyses.”
Quote in the paperSubstantial claim
- Classified as probably not a substantial claim. 41
- May combine two claims. 42
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationCTE stage (I to IV) is based on extent and severity of ptau pathology.
“The stage of CTE (I to IV) is based on the extent and severity of ptau pathology (8).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [8] McKee, 2013, The spectrum of disease in chronic traumatic encephalopathy, Brain source
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationALS onset is most often sporadic, with approximately 10% of cases considered familial; there is a known genetic component for approximately 5%-10% of sporadic cases and 60% of familial cases.
“ALS onset is most often sporadic, with approximately 10% of cases considered familial.There is a known genetic component for approximately 5%-10% of sporadic cases and 60% of familial cases (12,13).”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [12] Logroscino, 2010, Incidence of amyotrophic lateral sclerosis in Europe, J Neurol Neurosurg Psychiatry source
The citation follows the sentence claiming known genetic components in 5%–10% of sporadic cases and 60% of familial cases. The Results section discusses regional differences in familial ALS cases, but neither it nor the passages retrieved for genetic components and those percentages addresses the claimed figures. (LLM, conf=0.75)
Experimental — accuracy not yet measured - cites [13] Tiryaki, 2014, ALS and other motor neuron diseases, Continuum (Minneap Minn) source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationPathologically, CTE is characterized by accumulation of hyperphosphorylated tau aggregated in neurons, astrocytes, and cell processes around small vessels and in depths of cerebral sulci.
“Pathologically, CTE is characterized by accumulation of hyperphosphorylated tau (ptau) that is aggregated in neurons, astrocytes, and cell processes around small vessels and in the depths of the cerebral sulci (7).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [7] McKee, 2016, The first NINDS/NIBIB consensus meeting to define neuropathological criteria for the diagnosis of chronic traumatic encephalopathy, Acta Neuropathol source
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationIncidence estimates for ALS range from about 2 to 3 per 100,000 people per year; ALS is more common in males and military veterans.
“Incidence estimates for ALS range from about 2 to 3 per 100 000 people per year; ALS is more common in males and military veterans (11,12).”
Quote in the paperNot a substantial claim2 of 2 sources checked- cites [11] Bieniek, 2015, Chronic traumatic encephalopathy pathology in a neurodegenerative disorders brain bank, Acta Neuropathol source
Split into 2 atoms — 0 confirmed, 0 partially supported, 0 disputed, 0 misattributed, 2 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured - cites [12] Logroscino, 2010, Incidence of amyotrophic lateral sclerosis in Europe, J Neurol Neurosurg Psychiatry source
Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationCognition is affected in a majority of ALS cases at some point in disease course.
“Cognition is also affected in a majority of cases at some point in the disease course (10).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [10] Strong, 2017, Amyotrophic lateral sclerosis—Frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria, Amyotroph Lateral Scler Frontotemporal Degener source
The Discussion reports that more than 50% of ALS patients prospectively assessed had some form of frontotemporal disruption or dementia. That category includes behavioural dysfunction, so it does not establish that cognition specifically is affected in a majority, nor does the passage establish the claim’s ‘at some point in the disease course’ timing. (LLM, conf=0.86)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationThe clinical syndrome of CTE includes behavioral, mood, and cognitive dysfunction as well as occasional extrapyramidal motor symptoms.
“The clinical syndrome of CTE continues to be refined but includes behavioral, mood, and cognitive dysfunction as well as occasional motor symptoms that are typically extrapyramidal (1,2).”
Quote in the paperNot a substantial claim2 of 2 sources checked- cites [1] McKee, 2009, Chronic traumatic encephalopathy in athletes: Progressive tauopathy after repetitive head injury, J Neuropathol Exp Neurol source
- cites [2] Gavett, 2011, Chronic traumatic encephalopathy: A potential late effect of sport-related concussive and subconcussive head trauma, Clin Sports Med source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationOther studies have not found a modifying effect of head injury on ALS.
“although other studies have not found a modifying effect of head injury on ALS (15).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [15] Fournier, 2015, Head injury does not alter disease progression or neuropathologic outcomes in ALS, Neurology source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationDFS score has been used to indicate functional progression and disease duration in other ALS cohorts.
“This score, the DFS score, has been used to indicate functional progression and disease duration in other ALS cohorts (25).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [25] Labra, 2016, Rate of disease progression: A prognostic biomarker in ALS, J Neurol Neurosurg Psychiatry source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationChen et al found individuals were 11 times more likely to develop ALS if they reported multiple head injuries within last 10 years prior to diagnosis.
“Chen et al found that individuals were 11 times more likely to develop ALS if they reported multiple head injuries within the last 10 years prior to diagnosis (14), although other studies have not found a modifying effect of head injury on ALS (15).”
Quote in the paperNot a substantial claim2 of 2 sources checked- cites [14] Chen, 2007, Head injury and amyotrophic lateral sclerosis, Am J Epidemiol source
The results (p. 811) report more than an 11-fold higher ALS risk among people with repeated head injuries whose latest injury occurred within 10 years before diagnosis. The claim implies that the multiple injuries all occurred within that period and omits that the estimate came from a post-hoc exploratory analysis based on small numbers. (LLM, conf=0.86)
Experimental — accuracy not yet measured - cites [15] Fournier, 2015, Head injury does not alter disease progression or neuropathologic outcomes in ALS, Neurology source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationEnvironmental factors are believed to play an important role in development of ALS.
“As a result, environmental factors are believed to play an important role in the development of ALS (12).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [12] Logroscino, 2010, Incidence of amyotrophic lateral sclerosis in Europe, J Neurol Neurosurg Psychiatry source
The Introduction (page unavailable) says environmental risk factors may be relevant to ALS pathogenesis, and the Discussion speculates that an environmental risk factor may contribute to differences in disease onset between men and women. The paper does not establish or assert that environmental factors play an important role in ALS development generally; it describes the cause of ALS as unknown. (LLM, conf=0.82)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationParticipants with ALS have been shown to have an elevated frequency of minor to major depressive symptoms of approximately 27%.
“Participants with ALS have been shown to have an elevated frequency of minor to major depressive symptoms of approximately 27% (42), which is similar to the frequency of mood disorders amongst the VABBB ALS participants (26%).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [42] Kehyayan, 2014, Profile of patients with amyotrophic lateral sclerosis across continuum of care, Can J Neurol Sci source
The Health and Social-Economic Profile table reports potential minor-to-major depressive episodes in 27.2% of ALS patients receiving home care, versus 14.5% of the home-care comparison group. The approximately 27% figure is supported for that setting, but not for ALS participants across all settings: the corresponding figures are 38.4% in nursing homes and 38.8% in complex continuing care. No page number is available in our copy. (LLM, conf=0.86)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationBulbar onset ALS has been associated with faster disease progression.
“Although bulbar onset ALS has been associated with faster disease progression (44), DFS rates were not significantly different between participants with ALSþCTE and ALS only although this analysis is likely underpowered due to the small number of participants with CTE.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [44] Chio, 2009, Prognostic factors in ALS: A critical review, Amyotroph Lateral Scler source
The Site of onset section says bulbar-onset ALS is associated with a worse prognosis than spinal-onset ALS. The review discusses progression rates separately, but does not establish that bulbar onset itself is associated with faster disease progression. (LLM, conf=0.85)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationIndividuals with a history of repetitive head impacts and CTE may be at risk for multiple neurodegenerations including beta-amyloid deposition and Lewy body disease.
“Moreover, individuals with a history of repetitive head impacts and CTE may be at risk for multiple neurodegenerations including bamyloid deposition (49) and Lewy body disease (50).”
Quote in the paperNot a substantial claim2 of 2 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationMost of the RHI exposures in this cohort have been previously related to the development of CTE, including bull riding.
“Most of these exposures have been previously related to the development of CTE, including bull riding, which was recently reported in association with CTE (41).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [41] Keene, 2018, First confirmed case of chronic traumatic encephalopathy in a professional bull rider, Acta Neuropathol source
May combine two claims.
PremisecitationThe presence of comorbid ALS+CTE in an ALS cohort parallels similar findings of CTE in neurodegenerative cohorts, e.g. 6% in an MSA cohort, 6% in an American football CTE group, and 11.9%-32% in a group of various diseases.
“The presence of comorbid ALSþCTE in an ALS cohort parallel similar findings of CTE in neurodegenerative cohorts, e.g.6% in an multiple system atrophy (MSA) cohort as reported by Koga et al (46), 6% in an American football CTE group (47) and 11.9%-32% in a group of various diseases reported by Ling et al (48).”
Quote in the paperNot a substantial claim2 of 3 sources checked- cites [46] Koga, 2016, Chronic traumatic encephalopathy pathology in multiple system atrophy, J Neuropathol Exp Neurol source
- cites [47] Mez, 2017, Clinicopathological evaluation of chronic traumatic encephalopathy in players of American football, JAMA source
The Discussion (page not available in our copy) reports comorbid motor neuron disease among football players with severe CTE pathology, supporting the comparison with ALS+CTE. It does not give a 6% figure for that comorbidity, so the specific percentage attributed to this paper is not verified. The MSA and other-disease figures are attributed to separate citations, not this source. (LLM, conf=0.83)
Experimental — accuracy not yet measured - cites [48] Ling, 2015, Histological evidence of chronic traumatic encephalopathy in a large series of neurodegenerative diseases, Acta Neuropathol source
May combine two claims.
FindingreasoningOne participant did not meet criteria for neuropathological diagnosis of ALS and was excluded, resulting in 155 deceased participants selected for study.
“One participant did not meet criteria for neuropathological diagnosis of ALS and was excluded, resulting in a total of 155 deceased participants selected for the study.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataIn entire cohort, 153 (99%) had neuropathologically confirmed ALS and 2 (1%) had motor neuron disease with prominent lower motor degeneration consistent with primary muscular atrophy.
“In the entire cohort, 153 (99%) had neuropathologically confirmed ALS and 2 (1%) had motor neuron disease with prominent lower motor degeneration consistent with primary muscular atrophy.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataMean age at onset was younger in ALS+CTE by about 7 years, although not significant (52.9 vs 59.9, p=0.096).
“Mean age at onset was younger in participants with co-morbid CTE by about 7 years, although this did not reach significance (52.9 years vs 59.9 years, p ¼ 0.096).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataOf 155 participants, 152 had available clinical medical records.
“Of the 155 participants, 152 had available clinical medical records.”
Quote in the paperNot a substantial claim- Rests on an assumption: Missing clinical medical records (3 ALS only) do not bias the comparisons.
May combine two claims.
Findingown dataStage distribution: one stage I, 4 stage II, 3 stage III, one stage IV.
“One participant was stage I, 4 participants were stage II, 3 participants were stage III, and one participant was stage IV.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataBetween groups, differences in number of mutations were not significant for C9orf72 (0% vs 3%, p=0.36) or all tested mutations (0% vs 10%, p=1.00), although comparison likely underpowered.
“Between the 2 groups, differences in the number of mutations were not significant for C9orf72 mutations (0% vs 3%, p ¼ 0.36), or for all tested mutations (0% vs 10%, p ¼ 1.00), although this comparison is likely underpowered.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataNine participants in ALS only group tested positive for known genetic mutation, and 3 had C9orf72 mutation.
“Nine participants in the ALS only group tested positive for a known genetic mutation, and 3 of these participants had a C9orf72 mutation.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingown dataEthnicity: 139 not Hispanic (89%), 2 Hispanic (1%), 14 missing (10%).
“With regards to ethnicity, 139 (89%) of participants were not Hispanic or Latino, 2 (1%) were Hispanic or Latino, and 14 (10%) did not provide information.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataOf 21 participants with history of either TBI or RHI, 9 (43%) had pathological diagnosis of CTE and 12 (57%) did not.
“Overall, there were a total of 21 participants with a history of either TBI or RHI: 9 (43%) had a pathological diagnosis of CTE (CTE-1-9) and 12 (57%) did not (ALS-1-12, Table 1).”
Quote in the paperSubstantial claim- Rests on an assumption: Clinical history data (TBI, RHI, mood, behavioral, cognitive) obtained from participant/proxy questionnaires and medical records accurately reflect participants' actual exposures and symptoms.
May combine two claims.
Findingown dataNo apparent differences between groups in progression of ALS symptoms: ALSFRS-R score at death (12.9 vs 12.8, p=0.989) and DFS (-0.5 vs -0.6, p=0.689) not significantly different.
“There were also no apparent differences between groups in the progression of ALS symptoms: the ALSFRS-R score at death (12.9 vs 12.8, p ¼ 0.989) and the DFS (À0.5 vs À0.6, p ¼ 0.689) were not significantly different between the groups.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataCohort was predominantly male (99%).
“The cohort was predominantly male (99%).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataService era distribution was significantly different between groups (χ2=17.7, p=0.013) such that ALS+CTE were less likely to serve in Vietnam (p<0.05) and more likely to have served in first Persian Gulf War (p<0.05).
“However, the service era distribution was significantly different between groups (v 2 ¼ 17.7, p ¼ 0.013) such that participants with ALSþCTE were less likely to serve in Vietnam (p < 0.05) and more likely to have served in the first Persian Gulf War (p < 0.05, Table 3).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataSince inception in 2006, VABBB enrolled 287 veterans with ALS.
“Since its inception in 2006, the VABBB has enrolled a total of 287 veterans with ALS.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataFor 152 participants with clinical records, 40 (26%) had mood changes or mood disorder, 12 (8%) behavioral changes, 12 (8%) cognitive impairment.
“For the 152 participants with clinical records, 40 (26%) had noted mood changes or a mood disorder diagnosis, 12 (8%) had behavioral changes, and 12 (8%) had cognitive impairment.”
Quote in the paperNot a substantial claim- Rests on an assumption: Clinical history data (TBI, RHI, mood, behavioral, cognitive) obtained from participant/proxy questionnaires and medical records accurately reflect participants' actual exposures and symptoms.
- Rests on an assumption: Missing clinical medical records (3 ALS only) do not bias the comparisons.
Probably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataIn 2 participants, head impact exposure was associated with military service.
“In 2 participants, head impact exposure was associated with military service.”
Quote in the paperNot a substantial claim- Rests on an assumption: Clinical history data (TBI, RHI, mood, behavioral, cognitive) obtained from participant/proxy questionnaires and medical records accurately reflect participants' actual exposures and symptoms.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingown dataALS disease duration ranged from 6 to 504 months with mean 126 and median 96.
“ALS disease duration ranged from 6 to 504 months with a mean duration of 126 months and median of 96 months.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingown dataTwenty-six (17%) had family history of neurological disease, and 13 (8%) had family history specific for ALS.
“Twenty-six (17%) had a family history of neurological disease, and of this group 13 (8%) had a family history specific for ALS.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataSixteen (11%) had record of at least 1 TBI, 12 (8%) had record of exposure to RHI, and 7 (5%) had history of both TBI and RHI.
“Sixteen (11%) had a record of at least 1 TBI, 12 (8%) had a record of exposure to a form of RHI (e.g.participation in contact sports), and 7 (5%) had a history of both TBI and RHI.”
Quote in the paperNot a substantial claim- Rests on an assumption: Clinical history data (TBI, RHI, mood, behavioral, cognitive) obtained from participant/proxy questionnaires and medical records accurately reflect participants' actual exposures and symptoms.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingown dataRace distribution: 138 White (89%), 4 Black (3%), 1 Asian (<1%), 10 missing (8%).
“One hundred thirtyeight participants were White (89%), 4 were Black or African American (3%), 1 was Asian (<1%), and 10 did not provide information (8%).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataAll 9 participants with ALS+CTE were male, and all had history of some form of head impact: 8 had history of at least 1 moderate to severe TBI, and 6 had confirmed history of RHI from contact or alternative sports or military-related activities.
“All 9 participants with ALSþCTE were male, and all had a history of some form of head impact: 8 had a history of at least 1 moderate to severe TBI, and 6 had confirmed history of RHI from contact or alternative sports or military-related activities.”
Quote in the paperNot a substantial claim- Rests on an assumption: Clinical history data (TBI, RHI, mood, behavioral, cognitive) obtained from participant/proxy questionnaires and medical records accurately reflect participants' actual exposures and symptoms.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingown dataMilitary branch distribution: Army 71 (46%), Navy 38 (24%), Air Force 31 (19%), Marines 8 (6%), Coast Guard 2 (1%), Army and Air Force 1 (<1%), unavailable 4 (3%).
“Veterans previously served in the following branches of the US Armed Forces: Army 71 (46%), Navy 38 (24%), Air Force 31 (19%), Marines 8 (6%), Coast Guard 2 (1%), Army and Air Force 1 (<1%), and information was unavailable for 4 (3%).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataNinety-eight participants were tested postmortem for genetic mutations known to be associated with neurological disease.
“Ninety-eight participants were tested postmortem for genetic mutations known to be associated with neurological disease.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataOne of 9 ALS+CTE (CTE-4) had family history of ALS, but genetic testing did not reveal known ALS mutations.
“One of the 9 participants with ALSþCTE (CTE-4) had a family history of ALS, but genetic testing on this subject did not reveal any known ALS mutations.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingown dataMean age at death was 70.3 years, median 71.8.
“The mean age at death was 70.3 years, and the median was 71.8 years.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingown dataAge at onset known for 140, mean 59.6 years.
“Age at onset of ALS symptoms was known for 140 participants, and the mean age at onset was 59.6 years.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataNo significant differences in total years of service or military branch between ALS and ALS+CTE.
“There were no significant differences in total number of years of service or in military branch between participants with ALS and ALSþCTE.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingown dataEight donors were White, and one was Asian.
“Eight donors were White, and one was Asian.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataMean time in active military service, based on available info for 149 participants, was 6.1 years.
“Mean time in active military service, based on available information for 149 participants, was 6.1 years.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataAll participants with ALS+CTE had tau-positive NFTs and 4/9 had tau-positive glial tangles.
“All participants with ALSþCTE had tau-positive NFTs and 4/9 had tau-positive glial tangles.”
Quote in the paperNot a substantial claim- Rests on an assumption: Semiquantitative tau pathology scores (0-3) reliably reflect severity of tau pathology.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingown dataOnset site: 65 (42%) lower extremity, 41 (27%) upper extremity, 21 (14%) bulbar, 1 (<1%) respiratory, unknown 25 (16%).
“Of the 153 participants with a neuropathologically confirmed ALS diagnosis, 65 (42%) of participants had lower extremity onset, 41 (27%) participants had upper extremity onset, 21 (14%) of participants had bulbar onset, and one (<1%) participant had respiratory onset.Onset site was unknown for the remaining 25 (16%) of participants.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataTDP-43 inclusions were present in 7 participants and involved frontal cortex in 3 (CTE-1,7,5).
“TDP-43 inclusions were present in 7 participants and involved the frontal cortex in 3 participants (CTE-1, CTE-7, and CTE-5).”
Quote in the paperNot a substantial claim- Rests on an assumption: Semiquantitative tau pathology scores (0-3) reliably reflect severity of tau pathology.
May combine two claims.
FindingcitationThe frequency of mood disorders amongst the VABBB ALS participants was 26%, similar to the 27% reported in ALS.
“Participants with ALS have been shown to have an elevated frequency of minor to major depressive symptoms of approximately 27% (42), which is similar to the frequency of mood disorders amongst the VABBB ALS participants (26%).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataAge of onset was lower in participants with CTE, though this difference did not reach statistical significance.
“Age of onset was lower in participants with CTE, though this difference did not reach statistical significance.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataWithin participants with ALS+CTE, RHI exposure was due to contact sports exposure in 4 (44%), military service in one (11%), and both in one (11%).
“Within participants with ALSþCTE, RHI exposure was due to contact sports exposure (e.g.tackle football) in 4 (44%), military service (frequent aircraft carrier landings) in one (11%), and both (bull riding and grenade blast exposure) in one (11%).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationCTE can only be definitely diagnosed postmortem, and prevalence and incidence remain unknown.
“Thus far, CTE can only be definitely diagnosed postmortem, and the prevalence and incidence of the disorder remain unknown (2,(5)(6)(7)(8)(9).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites (2,(5)(6)(7)(8)(9)
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationRepetitive head impacts, including concussion and subconcussion, may result from contact sports, military-related activities, and motor vehicle accidents.
“Repetitive head impacts, including concussion and subconcussion, may result from a number of sources including participation in contact sports, military-related activities, and motor vehicle accidents (1)(2)(3)(4).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites (1)(2)(3)(4)
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationThe clinical presentation of CTE is typically insidious and often occurs years after the traumatic exposure.
“The clinical presentation of CTE is typically insidious and often occurs years after the traumatic exposure (1,2,(4)(5)(6).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites (1,2,(4)(5)(6)
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenProcedures were in accordance with ethical standards required by VA Boston Healthcare System IRB and VA Office of Research and Development.
“Procedures were in accordance with ethical standards required by the VA Boston Healthcare System Institutional Review Board and VA Office of Research and Development.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenNeuropathologists were blinded to clinical features of participants.
“Neuropathologists were blinded to clinical features of the participants.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataSeptal abnormalities could not be optimally assessed due to midline cut necessary to process half cerebrum for freezing and half for fixation.
“Septal abnormalities could not be optimally assessed due to the midline cut necessary to process half the cerebrum for freezing and half for fixation.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationUS military veterans have increased frequency of ALS, and veteran population has higher head injury prevalence than comparable civilian population.
“US military veterans have an increased frequency of ALS, and the veteran population has higher head injury prevalence than the comparable civilian population (16)(17)(18).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites (16)(17)(18)
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductcitationALSFRS-R is a widely used and validated measure to evaluate functional status in ALS.
“The ALSFRS-R is a widely used and validated measure to evaluate functional status in ALS (20).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [20] Kollewe, 2008, ALSFRS-R score and its ratio: A useful predictor for ALS-progression, J Neurol Sci source
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitationAdministration of ALSFRS-R by trained non-clinicians has been demonstrated to have exemplary inter-rater, intra-rater, and telephone-administered reliability.
“The administration of the ALSFRS-R by trained non-clinicians has been demonstrated to have exemplary inter-rater, intra-rater, and telephone-administered reliability (21).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [21] Kaufmann, 2007, and telephone‐administered reliability of the ALSFRS‐R in a multicenter clinical trial, Amyotroph Lateral Scler source
May combine two claims.
Interpretationown dataOverall, compared with ALS in isolation, comorbid ALS+CTE is associated with a history of TBI and has a distinct clinical and pathological presentation.
“Overall, compared with ALS in isolation, comorbid ALSþCTE is associated with a history of TBI and has a distinct clinical and pathological presentation.”
Quote in the paperSubstantial claim- Rests on an assumption: Clinical history data (TBI, RHI, mood, behavioral, cognitive) obtained from participant/proxy questionnaires and medical records accurately reflect participants' actual exposures and symptoms.
- Rests on an assumption: Semiquantitative tau pathology scores (0-3) reliably reflect severity of tau pathology.
- Rests on an assumption: The VABBB cohort of deceased veterans with ALS is not systematically biased in ways that affect comparisons between ALS+CTE and ALS only.
May combine two claims.
PremisecitationThe VABBB follows veterans with ALS or related motor neuron disorders during life and collects CNS tissue after death.
“The VABBB follows veterans with ALS or related motor neuron disorders during life and then collects, processes, and stores CNS tissue after death (19).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [19] Greenfield, 2008
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationThe VABBB is a longitudinal research project and tissue repository that collects functional, disease progression, and neuropathological data from enrolled veterans across the United States.
“The Department of Veterans Affairs Biorepository Brain Bank (VABBB) is a longitudinal research project and tissue repository that collects extensive functional, disease progression, and neuropathological data from enrolled veterans across the United States (18).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [18] Brady, 2013, The Department of Veterans Affairs Biorepository Brain Bank: A national resource for amyotrophic lateral sclerosis research, Amyotroph Lateral Scler Frontotemporal Degener source
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenVeterans were initially enrolled via outreach to the Durham VA ALS Registry and subsequently through passive methods such as online articles, use of a website, and unsolicited referrals from clinics aware of the project, all of which may introduce bias.
“Veterans were initially enrolled via outreach to the Durham VA ALS Registry and subsequently through passive methods such as online articles, use of a website, and unsolicited referrals from clinics aware of the project, all of which may introduce bias.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationCTE is often associated with mood and behavioral dysfunction.
“CTE is often associated with mood and behavioral dysfunction (6).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [6] Daneshvar, 2015, Post-traumatic neurodegeneration and chronic traumatic encephalopathy, Mol Cell Neurosci source
May combine two claims.
InterpretationreasoningVeterans' exposure to combat, combat training, and contact sports may predispose them to head injuries to a greater degree than the general population, limiting the generalizability of the study.
“Veterans are at increased risk for ALS development (51) and their exposure to combat, combat training, and contact sports may predispose them to head injuries to a greater degree than the general population, limiting the generalizability of the study.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Interpretationnone givenBoth ALS and MSA populations are at a high risk of falls after the onset of neurological disease.
“The prevalence of CTE found in an MSA cohort is similar to the prevalence found in this study (5.8%), and both populations are at a high risk of falls after the onset of neurological disease.”
Quote in the paperNot a substantial claim
The paper relies on this without support.
Clinical history data (TBI, RHI, mood, behavioral, cognitive) obtained from participant/proxy questionnaires and medical records accurately reflect participants' actual exposures and symptoms.
“Longitudinal clinical data was collected via telephone interview of the participant (or proxy in cases where the participant was unable to speak), questionnaires completed via the mail, and medical record review by study staff using the VA's Compensation and Pension Record Interchange medical record system (18).”
The paper relies on this without support.
Semiquantitative tau pathology scores (0-3) reliably reflect severity of tau pathology.
“Tau pathology in the dorsolateral frontal cortex and spinal cord was scored on a semiquantitative scale from 0 to 3.”
The paper relies on this without support.
The VABBB cohort of deceased veterans with ALS is not systematically biased in ways that affect comparisons between ALS+CTE and ALS only.
“Of the 287 total participants enrolled, 156 were deceased with a complete neuropathological evaluation with cortical and spinal cord tau immunostaining for the current analyses.”
The paper relies on this without support.
Missing clinical medical records (3 ALS only) do not bias the comparisons.
“All 3 of the cases missing clinical medical records were participants with ALS only.”
The paper relies on this without support.
Veterans are at risk for CTE from exposure to multiple sources of trauma, including combat-related activities, blast exposures, training exercises, recreational activities, as well as motor vehicle accidents, falls, and contact sports participation.
“In addition, veterans are at risk for CTE from exposure to multiple sources of trauma, including combat-related activities, blast exposures, training exercises, recreational activities, as well as motor vehicle accidents, falls, and contact sports participation.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Army and Air Force branch counts conflict across sections
MajorThe cohort summary reports 71 Army and 31 Air Force veterans, while Table 3 reports 28 plus 3 Army veterans and 68 plus 3 Air Force veterans. The totals appear reversed.
“Army 71 (46%), Navy 38 (24%), Air Force 31 (19%)”
“| Army | 28 (20%) | 3 (33%) | | | Air Force | 68 (48%) | 3 (33%) | |”
Percentage with missing race information is incorrect
MinorTen participants out of 155 is 6.5%, not the reported 8%.
Reported 8 · recomputed 6.451613
“10 did not provide information (8%).”
Overall male percentage conflicts with group counts
MinorTable 2 reports 143 male participants with ALS only and 9 with ALS and CTE. Together, 152 of 155 participants were male, or approximately 98%, rather than 99%.
“The cohort was predominantly male (99%).”
“Gender, n male (%) | 143 (98%) | 9 (100%) | 0.835 §”
DFS formulas have opposite signs
MinorThe Methods subtract the baseline score from 48, whereas the Table 2 footnote subtracts 48 from the baseline score. These definitions yield progression rates with opposite signs.
“DFS ¼ (48 -ALSFRS-R at baseline)/(disease duration)”
“DFS ¼ (ALSFRS at baseline -48)/(disease”
Six cases are listed for a count of five
MinorThe statement reports corpus callosum thinning in five participants but names six cases.
“thinning of the posterior aspect of the corpus callosum in 5”
“CTE-3, CTE-4, CTE-5, CTE-6, CTE-8, and CTE-9”
Marine participant with CTE is absent from Table 3
MinorThe case descriptions identify CTE-9 as a Marine veteran, but Table 3 reports no Marines in the ALS-plus-CTE group.
“CTE-9 was a Marine veteran of the Persian Gulf War era”
“| Marines | 8 (6%) | 0( 0 %) | |”
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · see citing works
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961 · see citing works
Phases of Aβ-deposition in the human brain and its relevance for the development of AD
Thal, D. R., Rüb, U., Orantes, M., & Braak, H. (2002) · Neurology · doi:10.1212/wnl.58.12.1791 · Cited by 3,490 · see citing works
Cedarbaum, J. M., Stambler, N., Malta, E., Fuller, C., Hilt, D., Thurmond, B., & Nakanishi, A. (1999) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(99)00210-5 · Cited by 3,307 · see citing works
Montine, T. J., Phelps, C. H., Beach, T. G., Bigio, E. H., Cairns, N. J., Dickson, D. W., Duyckaerts, C., Frosch, M. P., Masliah, E., Mirra, S. S., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-011-0910-3 · Cited by 2,992 · see citing works
Chronic traumatic encephalopathy in athletes: Progressive tauopathy after repetitive head injury
McKee, A. C., Cantu, R. C., Nowinski, C. J., Hedley-Whyte, E. T., Gavett, B. E., Budson, A. E., Santini, V. E., Lee, H.-S., Kubilus, C. A., & Stern, R. A. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181a9d503 · Cited by 2,295 · see citing works
Self-citationThe spectrum of disease in chronic traumatic encephalopathy
McKee, A. C., Stein, T. D., Nowinski, C. J., Stern, R. A., Daneshvar, D. H., Alvarez, V. E., Lee, H.-S., Hall, G., Wojtowicz, S. M., Baugh, C. M., et al. (2013) · Brain · doi:10.1093/brain/aws307 · Cited by 2,098 · see citing works
Self-citationPrognostic factors in ALS: A critical review
Chiò, A., Logroscino, G., Hardiman, O., Swingler, R., Mitchell, D., Beghi, E., Traynor, B. G., & On Behalf of the Eurals Consortium (2009) · Amyotrophic Lateral Sclerosis · doi:10.3109/17482960802566824 · Cited by 1,172 · see citing works
Cairns, N. J., Bigio, E. H., Mackenzie, I. R. A., Neumann, M., Lee, V. M.-Y., Hatanpaa, K. J., White, C. L., Schneider, J. A., Grinberg, L. T., Halliday, G., et al. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0237-2 · Cited by 1,110 · see citing works
Clinicopathological evaluation of chronic traumatic encephalopathy in players of American football
Mez, J., Daneshvar, D. H., Kiernan, P. T., Abdolmohammadi, B., Alvarez, V. E., Huber, B. R., Alosco, M. L., Solomon, T. M., Nowinski, C. J., McHale, L., et al. (2017) · JAMA · doi:10.1001/jama.2017.8334 · Cited by 1,098 · see citing works
Self-citationStages of pTDP‐43 pathology in amyotrophic lateral sclerosis
Brettschneider, J., Del Tredici, K., Toledo, J. B., Robinson, J. L., Irwin, D. J., Grossman, M., Suh, E., Van Deerlin, V. M., Wood, E. M., Baek, Y., et al. (2013) · Annals of Neurology · doi:10.1002/ana.23937 · Cited by 1,065 · see citing works
Mackenzie, I. R. A., Neumann, M., Bigio, E. H., Cairns, N. J., Alafuzoff, I., Kril, J., Kovacs, G. G., Ghetti, B., Halliday, G., Holm, I. E., et al. (2010) · Acta Neuropathologica · doi:10.1007/s00401-009-0612-2 · Cited by 1,012 · see citing works
Strong, M. J., Abrahams, S., Goldstein, L. H., Woolley, S., Mclaughlin, P., Snowden, J., Mioshi, E., Roberts-South, A., Benatar, M., HortobáGyi, T., et al. (2017) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2016.1267768 · Cited by 909 · see citing works
the TBI/CTE group, McKee, A. C., Cairns, N. J., Dickson, D. W., Folkerth, R. D., Dirk Keene, C., Litvan, I., Perl, D. P., Stein, T. D., Vonsattel, J.-P., et al. (2016) · Acta Neuropathologica · doi:10.1007/s00401-015-1515-z · Cited by 885 · see citing works
Self-citationStaging of Alzheimer-Related Cortical Destruction
Braak, H., Braak, E., & Bohl, J. (2008) · European Neurology · doi:10.1159/000116984 · Cited by 836 · see citing works
Where Does Parkinson Disease Pathology Begin in the Brain?
Del Tredici, K., Rüb, U., de Vos, R. A. I., Bohl, J. R. E., & Braak, H. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.5.413 · Cited by 773 · see citing works
Incidence of amyotrophic lateral sclerosis in Europe
Logroscino, G., Traynor, B. J., Hardiman, O., Chio, A., Mitchell, D., Swingler, R. J., Millul, A., Benn, E., Beghi, E., & EURALS, F. (2010) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2009.183525 · Cited by 772 · see citing works
Gavett, B. E., Stern, R. A., & McKee, A. C. (2011) · Clinics in Sports Medicine · doi:10.1016/j.csm.2010.09.007 · Cited by 696 · see citing works
Self-citationEpidemiology of mild traumatic brain injury and neurodegenerative disease
Gardner, R. C., & Yaffe, K. (2015) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2015.03.001 · Cited by 673 · see citing works
McKeith, I. G. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-9s347 · Cited by 625 · see citing works
Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS
文治, 木., Fujimura, C., Ishida, S., Nakajima, H., Furutama, D., Uehara, H., Shinoda, K., Sugino, M., & Hanafusa, T. (2006) · Neurology · doi:10.1212/01.wnl.0000194316.91908.8a · Cited by 568 · see citing works
Role of subconcussion in repetitive mild traumatic brain injury
Bailes, J. E., Petraglia, A. L., Omalu, B. I., Nauman, E. A., & Talavage, T. M. (2013) · Journal of neurosurgery · doi:10.3171/2013.7.jns121822 · Cited by 549 · see citing works
Invited Article: Nervous system pathology in sporadic Parkinson disease
Braak, H., & Tredici, K. D. (2008) · Neurology · doi:10.1212/01.wnl.0000312279.49272.9f · Cited by 536 · see citing works
Severely increased risk of amyotrophic lateral sclerosis among Italian professional football players
Chio, A. (2005) · Brain · doi:10.1093/brain/awh373 · Cited by 484 · see citing works
The central nervous system in motor neurone disease
Brownell, B., Oppenheimer, D. R., & Hughes, J. T. (1970) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.33.3.338 · Cited by 483 · see citing works
Perry, D. C., Sturm, V. E., Peterson, M. J., Pieper, C. F., Bullock, T., Boeve, B. F., Miller, B. L., Guskiewicz, K. M., Berger, M. S., Kramer, J. H., et al. (2016) · Journal of Neurosurgery · doi:10.3171/2015.2.jns14503 · Cited by 440 · see citing works
Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS
Gordon, P. H., & Cheung, Y. K. (2006) · Neurology · doi:10.1212/01.wnl.0000243812.25517.87 · Cited by 435 · see citing works
Love, S., Louis, D. N., & Ellison, D. W. (2008) · CRC Press eBooks · doi:10.1201/b22602 · Cited by 435 · see citing works
Emerging histomorphologic phenotypes of chronic traumatic encephalopathy in American athletes
Omalu, B., Bailes, J., Hamilton, R. L., Kamboh, M. I., Hammers, J., Case, M., & Fitzsimmons, R. (2011) · Neurosurgery · doi:10.1227/neu.0b013e318212bc7b · Cited by 381 · see citing works
Chronic traumatic encephalopathy pathology in a neurodegenerative disorders brain bank
Bieniek, K. F., Ross, O. A., Cormier, K. A., Walton, R. L., Soto-Ortolaza, A., Johnston, A. E., DeSaro, P., Boylan, K. B., Graff-Radford, N. R., Wszolek, Z. K., et al. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1502-4 · Cited by 323 · see citing works
Self-citationBeta-amyloid deposition in chronic traumatic encephalopathy
Stein, T. D., Montenigro, P. H., Alvarez, V. E., Xia, W., Crary, J. F., Tripodis, Y., Daneshvar, D. H., Mez, J., Solomon, T., Meng, G., et al. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1435-y · Cited by 291 · see citing works
Self-citationNewell, K. L., Hyman, B. T., Growdon, J. H., & Hedley-Whyte, E. T. (1999) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199911000-00004 · Cited by 289 · see citing works
Cedarbaum, J. M., & Stambler, N. (1997) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(97)00237-2 · Cited by 284 · see citing works
Neuropathology of amyotrophic lateral sclerosis and its variants
Saberi, S., Stauffer, J. E., Schulte, D. J., & Ravits, J. (2015) · Neurologic Clinics · doi:10.1016/j.ncl.2015.07.012 · Cited by 282 · see citing works
Head Injury and Amyotrophic Lateral Sclerosis
Chen, H., Richard, M., Sandler, D. P., Umbach, D. M., & Kamel, F. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm153 · Cited by 279 · see citing works
ALSFRS-R score and its ratio: A useful predictor for ALS-progression
Kollewe, K., Mauss, U., Krampfl, K., Petri, S., Dengler, R., & Mohammadi, B. (2008) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2008.07.016 · Cited by 253 · see citing works
Rate of disease progression: A prognostic biomarker in ALS
Labra, J., Menon, P., Byth, K., Morrison, S., & Vucic, S. (2016) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2015-310998 · Cited by 209 · see citing works
Kaufmann, P., Levy, G., Montes, J., Buchsbaum, R., Barsdorf, A. I., Battista, V., Arbing, R., Gordon, P. H., Mitsumoto, H., Levin, B., et al. (2007) · Amyotrophic Lateral Sclerosis · doi:10.1080/17482960600888156 · Cited by 145 · see citing works
HART, M. N. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181839bfd · Cited by 145 · see citing works
ALS and other motor neuron diseases
Tiryaki, E., & Horak, H. A. (2014) · Continuum · doi:10.1212/01.con.0000455886.14298.a4 · Cited by 143 · see citing works
Blauwendraat, C., Faghri, F., Pihlstrøm, L., Geiger, J. T., Elbaz, A., Lesage, S., Corvol, J., May, P., Nicolas, A., Abramzon, Y. A., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.05.009 · Cited by 143 · see citing works
Post-traumatic neurodegeneration and chronic traumatic encephalopathy
Daneshvar, D. H., Goldstein, L. E., Kiernan, P. T., Stein, T. D., & McKee, A. C. (2015) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2015.03.007 · Cited by 130 · see citing works
Self-citationAssociation of ALS with head injury, cigarette smoking and APOE genotypes
Schmidt, S., Kwee, L. C., Allen, K. D., & Oddone, E. Z. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2010.01.011 · Cited by 117 · see citing works
Lewy body pathology and chronic traumatic encephalopathy associated with contact sports
Adams, J. W., Alvarez, V. E., Mez, J., Huber, B. R., Tripodis, Y., Xia, W., Meng, G., Kubilus, C. A., Cormier, K., Kiernan, P. T., et al. (2018) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nly065 · Cited by 109 · see citing works
Self-citationLing, H., Holton, J. L., Shaw, K., Davey, K., Lashley, T., & Revesz, T. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1496-y · Cited by 106 · see citing works
Prognostic factors in ALS: A critical review
Chiò, A., Logroscino, G., Hardiman, O. M., Swingler, R. J., Mitchell, D. J., Beghi, E., Traynor, B. J., & On Behalf of the EURALS Consortium (2008) · Amyotrophic Lateral Sclerosis · doi:10.1080/17482960802566824 · Cited by 66 · see citing works
Pathologic Thr <sup>175</sup> tau phosphorylation in CTE and CTE with ALS
Moszczynski, A. J., Strong, W., Xu, K., McKee, A., Brown, A., & Strong, M. J. (2018) · Neurology · doi:10.1212/wnl.0000000000004899 · Cited by 59 · see citing works
Self-citationChronic traumatic encephalopathy pathology in multiple system atrophy
Koga, S., Dickson, D. W., & Bieniek, K. F. (2016) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlw073 · Cited by 58 · see citing works
Military Service and Amyotrophic Lateral Sclerosis in a Population-based Cohort
Weisskopf, M. G., Cudkowicz, M., & Johnson, N. F. (2015) · Epidemiology · doi:10.1097/ede.0000000000000376 · Cited by 46 · see citing works
Head injury does not alter disease progression or neuropathologic outcomes in ALS
Fournier, C. N., Gearing, M., Upadhyayula, S. R., Klein, M., & Glass, J. D. (2015) · Neurology · doi:10.1212/wnl.0000000000001522 · Cited by 44 · see citing works
Update on Recent Molecular and Genetic Advances in Frontotemporal Lobar Degeneration
Bigio, E. H. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31817d751c · Cited by 40 · see citing works
First confirmed case of chronic traumatic encephalopathy in a professional bull rider
Keene, C. D., Latimer, C. S., Steele, L. M., & Mac Donald, C. L. (2018) · Acta Neuropathologica · doi:10.1007/s00401-017-1801-z · Cited by 22 · see citing works
Brady, C. B., Trevor, K. T., Stein, T. D., Deykin, E. Y., Perkins, S. D., Averill, J. G., Guilderson, L., Mckee, A. C., Renner, S. W., & Kowall, N. W. (2013) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2013.822516 · Cited by 19 · see citing works
Self-citationProfile of patients with amyotrophic lateral sclerosis across continuum of care
Kehyayan, V., Korngut, L., Jetté, N., & Hirdes, J. P. (2014) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100016656 · Cited by 14 · see citing works
Author response: Pathologic Thr 175 tau phosphorylation in CTE and CTE with ALS
Strong, M. J. (2018) · Neurology · doi:10.1212/wnl.0000000000006194 · Cited by 14 · see citing works
Military service and amyotrophic lateral sclerosis in a US population-based cohort (S36.005)
Weisskopf, M. G., Cudkowicz, M., & Johnson, N. F. (2015) · Neurology · doi:10.1212/wnl.84.14_supplement.s36.005
Head Injury Does Not Alter Disease Progression or Neuropathological Outcomes in ALS (S24.003)
Fournier, C. N., Gearing, M., Upadhyayula, S. R., et al. (2015) · Neurology · doi:10.1212/wnl.84.14_supplement.s24.003
Strong, M. J., Abrahams, S., Goldstein, L. H., et al. (2017) · Figshare · doi:10.6084/m9.figshare.4609483
Flagged first, then by citations
Research works printed but not linked: 1
- Cedarbaum, 1997, J Neurol Sci, S1
Cited by
Sorted by citations
Traumatic Brain Injury and Risk of Neurodegenerative Disorder
Brett, B. L., Gardner, R. C., Godbout, J. P., Dams-O’Connor, K., & Keene, C. D. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2021.05.025 · Cited by 439 · see citing works
Katz, D. I., Bernick, C. B., Dodick, D. W., Mez, J. B., Mariani, M. L., Adler, C. H., Alosco, M. L., Balcer, L. J., Banks, S. J., Barr, W., et al. (2021) · Neurology · doi:10.1212/wnl.0000000000011850 · Cited by 345 · see citing works
“The inclusion of motor neuron disease as a supportive feature is based on preliminary research indicating an association between motor neuron disease and CTE neuropathology in a small number of individuals with a history of RHI exposure.(31,32)”
BackgroundSelf-citationMcKee, A. C., Stein, T. D., Huber, B. R., Crary, J. F., Bieniek, K., Dickson, D., Alvarez, V. E., Cherry, J. D., Farrell, K., Butler, M., et al. (2023) · Acta Neuropathologica · doi:10.1007/s00401-023-02540-w · Cited by 244 · see citing works
“Relationship between RHI, CTE, TDP‑43, and ALS Although CTE is defined by a unique pattern of p-tau pathology, other neurodegenerative pathologies may be affected by RHI exposure and CTE, including beta-amyloid plaques [111], cerebral amyloid angiopathy [110], and Lewy body disease [3].”
BackgroundInfluentialSelf-citationNowinski, C. J., Bureau, S. C., Buckland, M. E., Curtis, M. A., Daneshvar, D. H., Faull, R. L. M., Grinberg, L. T., Hill-Yardin, E. L., Murray, H. C., Pearce, A. J., et al. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.938163 · Cited by 183 · see citing works
“Similarly, investigators at other North American institutions have published studies that describe the presence of CTE pathology in military veterans (60) and former athletes in American football (10, 23, 24, 61–64), amateur and professional wrestling (23, 65), and ice hockey (24).”
BackgroundMethodInfluentialBieniek, K. F., Blessing, M. M., Heckman, M. G., Diehl, N. N., Serie, A. M., Paolini, M. A., Boeve, B. F., Savica, R., Reichard, R. R., & Dickson, D. W. (2019) · Brain Pathology · doi:10.1111/bpa.12757 · Cited by 119 · see citing works
The amyotrophic lateral sclerosis exposome: recent advances and future directions
Goutman, S. A., Savelieff, M. G., Jang, D., Hur, J., & Feldman, E. L. (2023) · Nature Reviews Neurology · doi:10.1038/s41582-023-00867-2 · Cited by 102 · see citing works
Iverson, G. L., Gardner, A. J., Shultz, S. R., Solomon, G. S., McCrory, P. R., ZAFONTE, R. D., Perry, G. L., Hazrati, L., Keene, C. D., & Castellani, R. J. (2019) · Brain · doi:10.1093/brain/awz286 · Cited by 99 · see citing works
Incidence of and Mortality From Amyotrophic Lateral Sclerosis in National Football League Athletes
Daneshvar, D. H., Mez, J., Alosco, M. L., Baucom, Z., Mahar, I., Baugh, C. M., Palominos, J. V., Weuve, J., Paganoni, S., Cantu, R. C., et al. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.38801 · Cited by 82 · see citing works
Self-citationVariation in TMEM106B in chronic traumatic encephalopathy
Cherry, J. D., Mez, J., Crary, J. F., Tripodis, Y., Alvarez, V. E., Mahar, I., Huber, B. R., Alosco, M. L., Nicks, R., Abdolmohammadi, B., et al. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0619-9 · Cited by 66 · see citing works
“Because TMEM106B has been implicated in several other neurodegenerations many of which can occur comorbid with CTE [39, 46], we excluded participants with”
Self-citationNicks, R., Clement, N. F., Alvarez, V. E., Tripodis, Y., Baucom, Z. H., Huber, B. R., Mez, J. B., Alosco, M. L., Aytan, N., Cherry, J. D., et al. (2023) · Acta Neuropathologica · doi:10.1007/s00401-023-02539-3 · Cited by 53 · see citing works
“Numerous other pathologies may be influenced by RHI and associated with CTE, including beta-amyloid plaques [57], cerebral amyloid angiopathy [56], motor neuron disease [13, 37, 42, 60], and FTLD.”
BackgroundSelf-citationStandring, O. J., Friedberg, J., Tripodis, Y., Chua, A. S., Cherry, J. D., Alvarez, V. E., Huber, B. R., Xia, W., Mez, J. B., Alosco, M. L., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-02031-x · Cited by 47 · see citing works
Self-citationMurray, H. C., Osterman, C., Bell, P., Vinnell, L., & Curtis, M. A. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01413-9 · Cited by 44 · see citing works
“Abbreviations AD: Alzheimer’s disease; ALS: Amyotrophic lateral sclerosis; ARTAG : Agingrelated tau astrogliopathy; CAA : Cerebral amyloid angiopathy; CTE: Chronic traumatic encephalopathy; ER: Endoplasmic reticulum; NFT: Neurofibrillary tangles; NUP-62: Nucleoporin 62; PART : Primary age-related tauopathy; TDP43: TAR…”
BackgroundInfluentialHead Injury and Amyotrophic Lateral Sclerosis: A Meta-Analysis
Liu, G., Ou, S., Cui, H., Li, X., Yin, Z., Gu, D., & Wang, Z. (2021) · Neuroepidemiology · doi:10.1159/000510987 · Cited by 41 · see citing works
Donison, N. S., Palik, J., Volkening, K., & Strong, M. J. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00842-z · Cited by 39 · see citing works
“Moreover, ALS is one of the most common comorbidities in CTE patients, and over 80% of CTE patients also present with concomitant TDP-43 pathology in late stages [9, 257].”
Association of Playing College American Football With Long-term Health Outcomes and Mortality
Phelps, A., Alosco, M. L., Baucom, Z., Hartlage, K., Palmisano, J. N., Weuve, J., Mez, J., Tripodis, Y., & Stern, R. A. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.8775 · Cited by 28 · see citing works
“17 ≥17 127 (59) 320 (50) Highest level of education Bachelor’s degree 113 (52) NA NA NA Master’s degree 51 (24) NA NA NA Doctoral or professional degree 52 (24) NA NA NA Married or domestic partnership 180 (84) 532 (83) .”
BackgroundTrauma and amyotrophic lateral sclerosis: a systematic review and meta-analysis
Gu, D., Ou, S., Tang, M., Yin, Z., Wang, Z., & Liu, G. (2021) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2020.1861024 · Cited by 26 · see citing works
“The probable explanation of these findings may be that repetitive traumatic events could trigger the development of chronic traumatic encephalopathy (CTE), a progressive neurodegeneration linked to repetitive head impacts and associated with ALS (50,51).”
BackgroundChronic Traumatic Encephalopathy and Neuropathological Comorbidities
Stein, T. D., & Crary, J. F. (2020) · Seminars in Neurology · doi:10.1055/s-0040-1713628 · Cited by 27 · see citing works
Self-citationLoBue, C., Schaffert, J., Cullum, C. M., Peters, M. E., Didehbani, N., Hart, J., & White, C. L. (2020) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2019-321567 · Cited by 22 · see citing works
Increased ISGylation in Cases of TBI-Exposed ALS Veterans
Schwartzenburg, J., Juncker, M. A., Reed, R. E., & Desai, S. D. (2018) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nly129 · Cited by 20 · see citing works
Neuropathological profile of long‐duration amyotrophic lateral sclerosis in military Veterans
Spencer, K. R., Foster, Z. W., Rauf, N. A., Guilderson, L., Collins, D., Averill, J. G., Walker, S. E., Robey, I., Cherry, J. D., Alvarez, V. E., et al. (2020) · Brain Pathology · doi:10.1111/bpa.12876 · Cited by 19 · see citing works
“The methods for data acquisition, neuropathological examination, clinical assessment/progression and genetic analysis have been described previously (12, 86).”
BackgroundMethodSelf-citationRecent Preclinical Insights Into the Treatment of Chronic Traumatic Encephalopathy
Breen, P., & Krishnan, V. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00616 · Cited by 19 · see citing works
“, 2018), amyotrophic lateral sclerosis (ALS) (Walt et al., 2018), and occasionally primary prionopathies (Nemani et al.”
BackgroundMicroRNA Alterations in Chronic Traumatic Encephalopathy and Amyotrophic Lateral Sclerosis
Alvia, M., Aytan, N., Spencer, K. R., Foster, Z. W., Rauf, N. A., Guilderson, L., Robey, I., Averill, J. G., Walker, S. E., Alvarez, V. E., et al. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.855096 · Cited by 16 · see citing works
Self-citationMazumder, S., Kiernan, M. C., Halliday, G. M., Timmins, H. C., & Mahoney, C. (2022) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12845 · Cited by 14 · see citing works
“Although the use of SOD1 models is widespread, it is somewhat surprising, albeit informative, to see only one study using brain bank material to confirm the similarity of disease biology in mouse and human tissue.67 Although, brain tissue has been used to better understand the molecular characteristics of SOD1 protein…”
BackgroundInfluentialCook, S. F., Rhodes, T., Schlusser, C. L., et al. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.770001 · Cited by 14 · see citing works
“(13) analyzed 287 VABBB participants with a diagnosis of ALS.”
BackgroundZedde, M., Piazza, F., & Pascarella, R. (2025) · Biomedicines · doi:10.3390/biomedicines13040881 · Cited by 12 · see citing works
“Growing evidence links prolonged contact-sport exposure and RHI to various neurodegenerative diseases [14–19].”
Brain pathology and symptoms linked to concussion history: beyond chronic traumatic encephalopathy
Taskina, D., Zhu, C., Schwab, N., & Hazrati, L. (2024) · Brain Communications · doi:10.1093/braincomms/fcad314 · Cited by 10 · see citing works
Recent Advances in Chronic Traumatic Encephalopathy
Babcock, K. J., Abdolmohammadi, B., & McKee, A. C. (2025) · American Journal Of Pathology · doi:10.1016/j.ajpath.2025.07.008 · Cited by 13 · see citing works
Self-citationChronic traumatic encephalopathy: understanding the facts and debate
LoBue, C., Schaffert, J., & Cullum, C. M. (2019) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000580 · Cited by 10 · see citing works
“including those with a history of alcohol use disorder [24], opioid/other substance use [37], schizophrenia with surgical leucotomy [38], temporal lobe epilepsy [39], amyotrophic lateral sclerosis [40], and multiple system atrophy as well as other neurodegenerative disorders [41].”
BackgroundCognitive Impairment and Dementia-Related Diagnoses in Chronic Traumatic Encephalopathy
LoBue, C., Bickart, K. C., Bieniek, K. F., Brett, B. L., Cabrera, H., Chiang, H., Sanotos, Y. D. L., Gonzales, M. M., Hart, J., Hernandez, R. S., et al. (2025) · Neurology · doi:10.1212/wnl.0000000000213934 · Cited by 8 · see citing works
Iverson, G. L., Jamshidi, P., Fisher‐Hubbard, A., Deep‐Soboslay, A., Hyde, T. M., Kleinman, J. E., deJong, J. L., Shepherd, C. E., Hazrati, L., & Castellani, R. J. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1143882 · Cited by 8 · see citing works
“Other studies involving brain banks have used sampling that is less than recommended by the consensus groups (7, 8, 13, 26, 27).”
BackgroundThe prevalence of chronic traumatic encephalopathy in a historical epilepsy post‐mortem collection
Ryniejska, M., Hachami, H. E., Mrzyglod, A., Liu, J. Y. W., & Thom, M. (2024) · Brain Pathology · doi:10.1111/bpa.13317 · Cited by 7 · see citing works
“Although not part of the diagnostic criteria of CTE [13], there is a close association between ARTAG and CTE [53] and they may represent a spectrum of the same disorder with ARTAG variably reported in 25% – 100% of CTE cases [14,18,29,32,33] (Table 2).”
Chronic Traumatic Encephalopathy in Soccer Players: Review of 14 Cases
Hageman, G., Hageman, I., & Nihom, J. (2023) · Clinical Journal of Sport Medicine · doi:10.1097/jsm.0000000000001174 · Cited by 8 · see citing works
Brady, C. B., Robey, I., Stein, T. D., Huber, B. R., Riley, J., Rauf, N. A., Spencer, K. R., Walt, G. S., Adams, L., Averill, J. G., et al. (2021) · Brain Sciences · doi:10.3390/brainsci11101349 · Cited by 4 · see citing works
Self-citationSmith, C. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85654-6.00010-1 · Cited by 4 · see citing works
Spinal Cord Tau and Protein Copathologies Associated With Chronic Traumatic Encephalopathy
Tanaka, H., Black, L. E., Forrest, S. L., Danics, K., Sadia, N., Khodadadi, M., Tator, C., Smith, D. H., Tartaglia, M. C., Stewart, W., et al. (2026) · JAMA Neurology · doi:10.1001/jamaneurol.2025.5421 · Cited by 4 · see citing works
Bate, J., Fealey, J., Young, C. A., McArdle, A., Staunton, C. A., & Close, G. L. (2026) · British Journal of Sports Medicine · doi:10.1136/bjsports-2025-111410 · Cited by 3 · see citing works
“56 CTE was historically associated with boxers and other fighting sports, due to the RHI.”
Prevalence and impact of comorbidities in amyotrophic lateral sclerosis
Jellinger, K. A. (2025) · Journal of Neural Transmission · doi:10.1007/s00702-025-02971-7 · Cited by 1 · see citing works
Clinicopathological study of chronic traumatic encephalopathy pathology in a population-based cohort
Rodriguez, R. D., Nowinski, C. J., Suemoto, C. K., Leite, R. E. P., Ferretti‐Rebustini, R. E. D. L., Filho, W. J., Pasqualucci, C. A., Nitríni, R., & Grinberg, L. T. (2025) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlaf150 · Cited by 2 · see citing works
Emerging Symptomatic Treatment of Chronic Traumatic Encephalopathy (CTE): a narrative review
Rossi, C. A., Campese, N., & Colosimo, C. (2023) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2023.2224501 · Cited by 1 · see citing works
The Luckiest Man onthe Face of the Earth
Hoenig, L. J. (2019) · The American Journal of Medicine · doi:10.1016/j.amjmed.2019.01.002
Scotton, K. (2019) · Iowa Research Online (University of Iowa)
Walker, M. A. (2021) · Scholarship@Western (Western University)
Professional Football Players Are at a Higher Risk for Amyotrophic Lateral Sclerosis
Talan, J. (2022) · Neurology Today · doi:10.1097/01.nt.0000821668.61482.08
Colvin, L. E., Foster, Z. W., Stein, T. D., Thakore‐James, M., Salajegheh, M. K., Carr, K., Spencer, K. R., Rauf, N. A., Adams, L., Averill, J. G., et al. (2022) · Muscle & Nerve · doi:10.1002/mus.27635
“These cases represent a subset of a previously reported sample from the VABBB cohort.(27,28) All assessments were completed between September 2012 and April 2020.”
ResultSelf-citationCan heading a ball cause dementia? The relationship between TBI and neurodegenerative diseases
Czerski, S., Rojek, K., Pawlus, A., Domasławski, D., Sabik, Ł., & Nowakowska-Kotas, M. M. (2026) · Issues of Rehabilitation Orthopaedics Neurophysiology and Sport Promotion – IRONS · doi:10.5114/irons/217706
“Coexisting ALS and CTE has been associated with prior TbI [53].”
- Authors
- Walt, G. S., Burris, H. M., Brady, C. B., Spencer, K. R., Alvarez, V. E., Huber, B. R., Guilderson, L., Abdul Rauf, N., Collins, D., Singh, T., Mathias, R., Averill, J. G., Walker, S. E., Robey, I., McKee, A. C., Kowall, N. W., & Stein, T. D.
- Affiliations
- VA Boston Healthcare System (US)
- Boston University (US)
- VA Boston Healthcare System, Boston, Massachusetts
- Southern Arizona VA Health Care System (US)
- Corresponding author
- Stein, Thor D
- Venue
- Journal of Neuropathology & Experimental Neurology
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-10-09
- Volume
- 77
- Issue
- 12
- Pages
- 1091-1100
- ISSN
- 0022-3069 (ISSN-L)
- 1554-6578
- PMC
- PMC6927868
- OpenAlex
- W2897778842
- Semantic Scholar
- 19bbbdaccdbff42f29ca8fd1022477309fd13d44
- Cited by
- 45
- References
- 54
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 2 · 2023: 6 · 2022: 8 · 2021: 8 · 2020: 4 · 2019: 6 · 2018: 2
- FWCI
- 3.40
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- public-domain
- Locations
- Journal of Neuropathology & Experimental Neurology (publishedVersion, public-domain)
- PubMed (publishedVersion)
- PubMed Central (submittedVersion)
- Funders
- NIH
- Topics
- Health Sciences › Medicine › Epidemiology › Traumatic Brain Injury Research
- Health Sciences › Medicine › Neurology › Amyotrophic Lateral Sclerosis Research
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Keywords
- chronic traumatic encephalopathy, amyotrophic lateral sclerosis, comorbidities, traumatic brain injury, tau pathology, veterans, Gulf War, bulbar onset, behavior change, mood changes, repetitive head impacts, contact sports, military service
- MeSH terms
- Chronic Traumatic Encephalopathy, Adult, Aged, Aged, 80 and over, Amyotrophic Lateral Sclerosis, Brain, Female, Humans, Longitudinal Studies, Male, Middle Aged, Tissue Banks, United States, United States Department of Veterans Affairs, Cohort Studies, Comorbidity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-18.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-18.
Cited sources are checked by gpt-6-sol.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review